Lonza Optimized Protocol
Optimization Guideline
Filter:
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols
or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our
optimization strategy to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Categories:
Primary Cells and Media, Transfection, Cell Lines and Primary Cancer Cells
Authors:
Dettmer-Monaco V, Weißert K, Ammann S, Monaco G, Lei L, Gräßel L, Rhiel M, Rositzka J, Kaufmann MM, Geiger K, Andrieux G, Lao J, Thoulass G, Schell C, Boerries M, Illert AL, Cornu TI, Ehl S, Aichele P, Cathomen T
In:
J Allergy Clin Immunol (2023) S0091: 6749(23)00989-2
Categories:
Transfection
Authors:
Damhofer H, Radzisheuskaya A, Helin K.
In:
STAR Protoc (2021) 2(2): 100575
Categories:
Classical Media and Reagents, Transfection
Authors:
Maria José Pino-Barrio , Yari Giménez, Mariela Villanueva , Marcus Hildenbeutel , Rebeca Sánchez-Dominguez , Sandra Rodríguez-Perales , Roser Pujol , Jordi Surrallés , Paula Río , Toni Cathomen , Claudio Mussolino , Juan Antonio Bueren , Susana Navarro
In:
Scientific Reports (2020) 10(1): 6997
Categories:
Transfection
Authors:
Ngoc Tung Tran , Thomas Sommermann , Robin Graf , Janine Trombke , Jenniffer Pempe , Kerstin Petsch , Ralf Kühn , Klaus Rajewsky , Van Trung Chu
In:
Cell Rep (2019) 28(13): 3510-3522
Categories:
Serum-free and Speciality Media
Authors:
de Bruin AM, Demirel Ö, Hooibrink B, Brandts CH, Nolte MA.
In:
Blood (2013) 121(18): 3578-85